John Egan, MD
Pulmonary Disease · Grand Rapids, MINPI 1295977221
Payments from drug & device makers
Across 62 payments — averaging $210.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$8K
- Cook Incorporated$3K
- Merit Medical Systems Inc$350
- Intuitive Surgical$349
- Galvanize Therapeutics, Inc$315
- Auris Health, Inc.$281
- plus $651 from 13 others
What the payments were for
- Consulting fees$7,35056%
- Speaking & faculty fees$3,15024%
- Travel & lodging$6595%
- Food & beverage$1,91015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 31 | $7,973 |
| Cook Incorporated | 1 | $3,150 |
| Merit Medical Systems Inc | 1 | $350 |
| Intuitive Surgical | 3 | $349 |
| Galvanize Therapeutics, Inc | 1 | $315 |
| Auris Health, Inc. | 2 | $281 |
| Medical Device Business Services, Inc. | 2 | $159 |
| Pulmonx Corporation | 3 | $122 |
| Olympus America Inc. | 2 | $110 |
| Ambu Inc. | 3 | $37 |
| Pinnacle Biologics, Inc | 2 | $37 |
| Sanofi | 2 | $31 |
| Electromed, Inc. | 3 | $28 |
| Edwards Lifesciences | 1 | $28 |
| Genentech USA, Inc. | 1 | $27 |
| AstraZeneca | 1 | $21 |
| Inari Medical, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Cook Medical LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monarch Platform$4,900
- Blue Rhino$3,150
- MONARCH$2,909
- Through The Scope$350
- ALIYA SYSTEM$315
- Da Vinci Surgical System$167
How this compares
$13,069 in reported general payments places this provider in the 80th percentile of 463 pulmonary disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $11,798 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Grand Rapids
- Gustavo Cumbo NacheliGrand Rapids$833K
- Reda GirgisGrand Rapids$491K
- Gayathri SathiyamoorthyGrand Rapids$181K
- Njira LugogoAnn Arbor$12.9M
- Timothy BlackwellAnn Arbor$2.5M
- Kevin FlahertyAnn Arbor$2.3M
- Meilan HanAnn Arbor$1.8M
- Gary FergusonLivonia$1.5M
- Justin OldhamAnn Arbor$1.4M
- Robert PaineAnn Arbor$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.